2008
DOI: 10.3171/foc/2008/25/7/e2
|View full text |Cite
|
Sign up to set email alerts
|

Biological basis for the surgical treatment of depression

Abstract: An estimated 20% of patients with major depression are refractory to existing therapies. The purpose of this review is to provide a theoretical and neuroscientific framework in which to interpret new work in the field of surgical treatment for depression. This review focuses on existing clinical and imaging data, current disease models, and results of recent case reports and patient series that together may inform the construction of appropriate clinical trials for the surgical treatment of refractory … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(20 citation statements)
references
References 135 publications
(121 reference statements)
0
20
0
Order By: Relevance
“…It is the leading cause of disability worldwide, as measured by years of life lived with a disability [109]. Some 20% of patients are refractory to the combination of behavioural, pharmacological and electroconvulsive therapy [110]. For these treatment-refractory patients, ablative stereotactic surgery has been proposed in the past, targeting limbic structures of the brain that are involved in the regulation of mood and affect.…”
Section: Refractory Depressionmentioning
confidence: 99%
“…It is the leading cause of disability worldwide, as measured by years of life lived with a disability [109]. Some 20% of patients are refractory to the combination of behavioural, pharmacological and electroconvulsive therapy [110]. For these treatment-refractory patients, ablative stereotactic surgery has been proposed in the past, targeting limbic structures of the brain that are involved in the regulation of mood and affect.…”
Section: Refractory Depressionmentioning
confidence: 99%
“…The physiological idea behind AC lesions is that interruption of the frontothalamic connections may attenuate negative ruminations that commonly accompany depression (Christensen et al, 2002;Abosch and Cosgrove, 2008), which may be mediated by self-reflective medial fronto-cortical 'resting state' and self-referential networks (Northoff et al, 2006;Northoff, 2010). More specifically, AC may be producing benefit by interrupting the connection between the anterior thalamic nucleus and cingulate gyrusFa component of Papez's limbic circuit that has been implicated in regulating emotionality (MacLean, 1990;Papez, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…ACT is used to treat refractory depression and OCD. The mechanism of therapeutic action remains uncertain, but it is commonly assumed to be due to disruption of one or more components of associated limbicemotional circuitry (Abosch and Cosgrove, 2008;Cho et al, 2008). More recently, studies evaluating the efficacy of ACT in major depression, drug dependence, and pain patients (Steele et al, 2008) suggest that the effects of ACT may be explained on the basis of disconnection of afferent fibers from the midline thalamic nuclei, the function of which is to impart the emotional coloring to perceptions (LeDoux, 1995), especially negative emotions (MacLean, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…Other arguments express the evolutionary strategy through comparison. For example, the article ''Biological Basis for the Surgical Treatment of Depression'' (Abosch and Cosgrove 2008), advocates for DBS using new models of depression as a systems-level disorder. The article emphasizes the scientific grounding for today's techniques by presenting a litany of improvements in contemporary psychosurgery:…”
Section: Managing the Memory Of Lobotomymentioning
confidence: 99%